comparemela.com
Latest Breaking News On - Chief executive brian goff - Page 1 : comparemela.com
Agios Stock Poised To Break Out On $905 Million Brain Cancer Deal
Agios agreed Tuesday to sell its 15% royalty in a brain cancer drug for $905 million upfront. Agios stock broke out at the open.
Brian-goff
Agios-pharmaceuticals
Drug-administration
Royalty-pharma
Chief-executive-brian-goff
vimarsana © 2020. All Rights Reserved.